MDRR vs PSTV vs GOOD vs NRXP

For growth investors, Gladstone Commercial Corporation (GOOD) is the stronger pick with 8.

0% revenue growth year-over-year, versus -10. 5% for Plus Therapeutics, Inc. (PSTV). Gladstone Commercial Corporation (GOOD) offers the better valuation at 31. 0x trailing P/E (83. 0x forward), making it the more compelling value choice. Analysts rate Gladstone Commercial Corporation (GOOD) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Gladstone Commercial Corporation (GOOD) delivered a total return of -9.

7%, compared to -99. 3% for Plus Therapeutics, Inc. (PSTV). Over 10 years, the gap is even starker: GOOD returned +51. 0% versus PSTV's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Medalist Diversified REIT, Inc.

(MDRR) is the lower-risk stock at -0. 35β versus NRx Pharmaceuticals, Inc. 's 1. 91β — meaning NRXP is approximately -649% more volatile than MDRR relative to the S&P 500. On balance sheet safety, Medalist Diversified REIT, Inc. (MDRR) carries a lower debt/equity ratio of 3% versus 3% for Gladstone Commercial Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Gladstone Commercial Corporation (GOOD) is pulling ahead at 8.

0% versus -10. 5% for Plus Therapeutics, Inc. (PSTV). On earnings-per-share growth, the picture is similar: Plus Therapeutics, Inc. grew EPS 100. 0% year-over-year, compared to -79. 2% for Medalist Diversified REIT, Inc.. Over a 3-year CAGR, PSTV leads at 185. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Gladstone Commercial Corporation (GOOD) is the more profitable company, earning 12.

0% net margin versus -23. 4% for NRx Pharmaceuticals, Inc. — meaning it keeps 12. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GOOD leads at 37. 2% versus -1324. 4% for NRXP. At the gross margin level — before operating expenses — PSTV leads at 91. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, GOOD (11.

4% yield), MDRR (4. 3% yield) pay a dividend. PSTV, NRXP do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Medalist Diversified REIT, Inc.

(MDRR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 35), 4. 3% yield). NRx Pharmaceuticals, Inc. (NRXP) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MDRR: -80. 2%, NRXP: -96. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MDRR (Real Estate) and PSTV (Healthcare) and GOOD (Real Estate) and NRXP (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MDRR is a small-cap income-oriented stock; PSTV is a small-cap quality compounder stock; GOOD is a small-cap income-oriented stock; NRXP is a small-cap quality compounder stock. MDRR, GOOD pay a dividend while PSTV, NRXP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.